L.M. Kohn & Company’s Thermo Fisher Scientific TMO Stock Holding History

L.M. Kohn & Company’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-794	Closed	-$322K	–	262
2025 Q2	$322K	Buy	794 +116	+17%	+$48.5K	0.09%	188
2025 Q1	$337K	Sell	678 -26	-4%	-$14.1K	0.09%	185
2024 Q4	$366K	Sell	704 -94	-12%	-$51.7K	0.09%	165
2024 Q3	$494K	Buy	798 +10	+1%	+$5.92K	0.13%	149
2024 Q2	$436K	Buy	788 +9	+1%	+$5.16K	0.12%	150
2024 Q1	$453K	Sell	779 -71	-8%	-$39.8K	0.13%	152
2023 Q4	$451K	Buy	850 +288	+51%	+$139K	0.14%	133
2023 Q3	$284K	Sell	562 -75	-12%	-$40K	0.1%	177
2023 Q2	$332K	Sell	637 -1	-0.2%	-$540	0.13%	150
2023 Q1	$367K	Sell	638 -19	-3%	-$10.7K	0.15%	140
2022 Q4	$362K	Sell	657 -85	-11%	-$45K	0.17%	138
2022 Q3	$377K	Buy	742 +9	+1%	+$5.04K	0.18%	137
2022 Q2	$398K	Buy	733 +46	+7%	+$25.3K	0.19%	137
2022 Q1	$406K	Buy	+687	New	+$395K	0.16%	154

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

L.M. Kohn & Company's TMO Position: Q3 2025 in Review

L.M. Kohn & Company sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 794 shares — an estimated $322K sold.

L.M. Kohn & Company first reported a position in TMO in Q1 2022 and held it in 14 quarters. The position peaked at $494K in Q3 2024. 2,515 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

L.M. Kohn & Company reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
L.M. Kohn & Company sold 794 Thermo Fisher Scientific shares in Q3 2025, an estimated $322K.
L.M. Kohn & Company first reported a position in Thermo Fisher Scientific in Q1 2022 and held it in 14 quarters.
L.M. Kohn & Company's Thermo Fisher Scientific position peaked at $494K in Q3 2024.
2,515 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on L.M. Kohn & Company's 13F filing for Q3 2025, filed 4 Nov 2025.